Target intelligence / Profile preview

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD) (PIK3CD)

Target
PIK3CD
Molecular classification
Enzyme
01

Overview

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD, also known as p110δ) is a class IA phosphoinositide 3-kinase (PI3K) catalytic isoform predominantly expressed in hematopoietic cells, particularly leukocytes. It plays a critical, non-redundant role in immune cell development, signaling, and function, acting downstream of antigen receptors (BCR and TCR), cytokine receptors, and chemokine receptors. Upon activation, PIK3CD phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which recruits and activates downstream effectors like AKT and mTOR to promote cell survival, proliferation, and migration. Dysregulation of PIK3CD is heavily implicated in human diseases; gain-of-function mutations in the PIK3CD gene cause Activated PI3K-delta Syndrome (APDS), a primary immunodeficiency characterized by lymphoproliferation, recurrent infections, and increased risk of lymphoma. Additionally, hyperactivation of PI3Kδ signaling is a hallmark of various B-cell malignancies, including chronic lymphocytic leukemia (CLL) and follicular lymphoma. Consequently, PIK3CD has become a major therapeutic target, with selective inhibitors like idelalisib and leniolisib approved for treating hematological cancers and APDS, respectively. However, therapeutic targeting of PI3Kδ is often limited by significant immune-mediated toxicities, such as colitis, hepatotoxicity, and pneumonitis.

Other names
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformPhosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit deltaPhosphoinositide-3-kinase catalytic subunit deltaPI3-kinase subunit deltaPI3K-deltaPI3KdeltaPtdIns-3-kinase subunit deltap110deltap110δp110D
02

Mechanism of action

Inhibition of phosphoinositide 3-kinase delta (PI3Kδ) catalytic activity, preventing the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3), thereby blocking downstream AKT/mTOR signaling pathways.

03

Biological functions

Signal transductionImmune responseCell proliferationCell survivalCell migration
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

HepatotoxicityColitisPneumonitisInfectionsNeutropeniaIntestinal perforation
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

PIK3CD mutationPIK3R1 mutationNaïve B cell percentagePhospho-AKT (p-AKT) levelsCD19+ B cell count

Beyond the preview

Go deeper on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD) (PIK3CD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD) (PIK3CD).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call